• Explore /
  • Poster
  • / Relationship between the number of positive MSI markers and the efficacy of NIVO+IPI therapy in MSI-H gastric cancer: A subgroup analysis of NO LIMIT study (WJOG13320G/CA209-7W7).

Relationship between the number of positive MSI markers and the efficacy of NIVO+IPI therapy in MSI-H gastric cancer: A subgroup analysis of NO LIMIT study (WJOG13320G/CA209-7W7).

Abstract Poster

Authors

null

Kenro Hirata

Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan

Kenro Hirata , Hisato Kawakami , Shigenori Kadowaki , Akitaka Makiyama , Masahiro Tsuda , Naotoshi Sugimoto , Nozomu Machida , Hiroki Hara , Hidekazu Hirano , Taito Esaki , Yoshito Komatsu , Shuichi Hironaka , Yasutaka Chiba , Kei Muro

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach and Other Gastrointestinal Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Tumor Biology, Biomarkers, and Pathology

Clinical Trial Registration Number

jRCT2080225304

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 386)

DOI

10.1200/JCO.2024.42.3_suppl.386

Abstract #

386

Poster Bd #

J9

Abstract Disclosures

Similar Posters

First Author: Rohit K. Jain

First Author: Heinz-Josef Lenz

First Author: Lorenzo Pilla

First Author: Charlee Nardin